HLS vs VIT

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

49LOW

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

HLS VIT
Technical
50
71
Catalyst
61
53
Sentiment
50
50
Fundamental
91
93
Momentum
37
34
Risk Gate
32
45

Key Metrics

HLS Metric VIT
$415.3MMarket Cap$26.5M
3.5MAvg Volume (20d)489K
+6.3%Short InterestN/A
$1.63552-Week High$0.084
$0.55752-Week Low$0.038
-0.5%Daily Change+2.6%
$0.572Entry Price$0.040
-69.3%ROE+1.2%
-12.3%Profit Margin+0.6%

Active Signals

HLS Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.3x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (1% of range)

VIT Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading below both moving averages — the trend is working against this one
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive

Ask Scout AI to compare HLS and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
HLS Full Analysis → VIT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).